Navigation Links
Novartis Makes Accessing Prescription Assistance and Disease Management Programs Simpler and Easier for Patients
Date:7/30/2008

ee Novartis medicines to qualified patients who experience financial hardships and who have no prescription drug coverage.

-- Novartis Disease Management and Education, offering resources on specific diseases, conditions and medicines in areas such as ADHD, asthma, cancer, cystic fibrosis, diabetes, eye health, hypertension, infectious diseases, Parkinson's Disease and senior health. Please visit http://www.PatientAssistanceNow.com for a complete list.

-- Novartis Clinical Trials, including information to help patients make educated decisions about participating in a clinical trial and understanding the clinical trial process.

-- Novartis Medicines, including links to information on Novartis prescription medications.

"Too many Americans feel frustrated and worried about their ability to get the medicines they need to manage their health. Many important prescription drug programs and educational resources offer assistance, yet unfortunately, few people know these exist or they have difficulty finding information," said Myrl Weinberg, President of the National Health Council. "By putting all the information in one place, programs such as Patient Assistance Now provide patients with easier access to information, including prescription drug assistance programs and disease education. Such programs play a vital role in helping patients get the care and resources they need."

Novartis is partnering with health organizations and working with healthcare providers and elected officials to spread further awareness about Patient Assistance Now to those who need help accessing the prescription medicines and health information they need.

"I applaud Novartis for taking action to address the need of all Americans to have access to quality healthcare," said Tommy G. Thompson, Former Secretary, US Department of Health and Human Services. "Uninsured patients are often sicker and ha
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case
2. Novartis, Pfizer and Merck Take the Lead on Strong Relationships with Physicians, as Doctors Demand an Expanding Set of Services
3. Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017
4. Novartis and Sony Pictures Television Internationals Latin American Advertising Sales Group Launch Partnership to Create Multi-Media Platform for Breast Cancer Awareness, Detection, and Treatment in Latin America
5. Watson and Novartis Settle Lawsuit Over Exelon(R) Patent Litigation
6. Novartis Vaccines to Host Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
7. Novartis Vaccines Partners With RediClinic for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
8. Colorado Influenza and Pneumococcal Alert Coalition (CIPAC) Partners with Novartis Vaccines for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
9. Novartis Vaccines Launches National Gift-Giving Program to Help Protect Loved Ones by Reserving an Influenza Vaccination
10. Dr. Web Makes Many Americans Question Trusted Health Providers
11. BCBSNC Makes Electronic Prescribing Available Statewide
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Circassia Raises GBP15 Million ($25 Million) in Oversubscribed Investment Round 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5Duke University Health System Chooses SSI for Revenue Cycle Claims Management 47794 1Duke University Health System Chooses SSI for Revenue Cycle Claims Management 47794 2Duke University Health System Chooses SSI for Revenue Cycle Claims Management 47794 3Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Technique to Treat Leukemia and Lymphoma 12449 1Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Technique to Treat Leukemia and Lymphoma 12449 2Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Technique to Treat Leukemia and Lymphoma 12449 3Lupus Foundation of America Fosters the Next Generation of Lupus Researchers by Awarding Gina M Finzi Memorial Student Summer Fellowships to Five Stu 4531 1Lupus Foundation of America Fosters the Next Generation of Lupus Researchers by Awarding Gina M Finzi Memorial Student Summer Fellowships to Five Stu 4531 2Lupus Foundation of America Fosters the Next Generation of Lupus Researchers by Awarding Gina M Finzi Memorial Student Summer Fellowships to Five Stu 4531 3